<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND:: Idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (IIH) is a syndrome consisting of <z:hpo ids='HP_0002315'>headache</z:hpo>, <z:hpo ids='HP_0001123'>visual field defects</z:hpo> and <z:hpo ids='HP_0001085'>papilledema</z:hpo> of uncertain etiology </plain></SENT>
<SENT sid="1" pm="."><plain>The prospect was raised previously as to an association between <z:e sem="disease" ids="C0020428" disease_type="Disease or Syndrome" abbrv="">aldosteronism</z:e> and <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> in 2 middle-aged women with IIH and <z:e sem="disease" ids="C1719312,C1384514" disease_type="Disease or Syndrome" abbrv="">primary aldosteronism</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PAL</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Since then, 2 additional adults were identified and 2 other cases were reported from the United Kingdom, whereas 6 cases of IIH and <z:e sem="disease" ids="C0271728" disease_type="Disease or Syndrome" abbrv="">secondary aldosteronism</z:e> (SAL) in children have been reported in the English literature worldwide </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS:: A retrospective analysis of cases from author institutions and published literature comparing clinical features, laboratory findings and therapeutic interventions in these 12 cases </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS:: The female-to-male ratio was 10:2 </plain></SENT>
<SENT sid="5" pm="."><plain>The mean age of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PAL</z:e> patients was 49 ± 3 years-<z:hpo ids='HP_0000001'>all</z:hpo> hypertensive, with adrenal pathology in most </plain></SENT>
<SENT sid="6" pm="."><plain>The mean age of the SAL patients was 11 ± 2 years-mostly normotensive, with 3 having <z:e sem="disease" ids="C0004775" disease_type="Disease or Syndrome" abbrv="">Bartter</z:e>'s and 2 Gitelman syndromes, and 1 renal congenital <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Plasma <z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> levels were elevated (31 ± 5 ng/dL) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PAL</z:e> and SAL, whereas plasma renin activity was suppressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PAL</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002900'>Hypokalemia</z:hpo> (3.2 ± 0.2 mmol/L), <z:hpo ids='HP_0002917'>hypomagnesemia</z:hpo> (1.6 ± 0.3 mg/dL) and a putative metabolic <z:hpo ids='HP_0001948'>alkalosis</z:hpo> (serum <z:chebi fb="0" ids="17544">HCO3</z:chebi> 30 ± 1 mmol/L) were observed </plain></SENT>
<SENT sid="9" pm="."><plain>IIH symptoms were controlled by <z:chebi fb="0" ids="9241">spironolactone</z:chebi> in 5, <z:chebi fb="0" ids="2639">amiloride</z:chebi> in 1, correction of <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> and <z:hpo ids='HP_0002917'>hypomagnesemia</z:hpo> in 2, discontinuation of <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drugs</z:chebi> in 2, and reduction of body weight in 1 </plain></SENT>
<SENT sid="10" pm="."><plain>One patient required serial lumbar punctures, 2 a ventriculoperitoneal shunt, whereas <z:hpo ids='HP_0000001'>all</z:hpo> 3 patients with <z:mp ids='MP_0009044'>adrenal adenoma</z:mp> underwent surgical resection </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS:: An association between IIH and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PAL</z:e> occurs in hypertensive middle-aged women, whereas normotensive girls having an inherited <z:hpo ids='HP_0000124'>renal tubular defect</z:hpo> may have IIH with SAL </plain></SENT>
<SENT sid="12" pm="."><plain>Patients with IIH should be evaluated for <z:e sem="disease" ids="C0020428" disease_type="Disease or Syndrome" abbrv="">aldosteronism</z:e> and considered for <z:chebi fb="0" ids="9241">spironolactone</z:chebi> therapy </plain></SENT>
</text></document>